Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Study limitation reported by the research below: “No brand name has been publicly confirmed for duvakitug; brand tag omitted.”